1. A simulation study comparing slope model with mixed‐model repeated measure to assess cognitive data in clinical trials of Alzheimer's disease. Issue 1 (17th January 2018) Authors: Chen, Yun‐Fei; Ni, Xiao; Fleisher, Adam S.; Zhou, Wei; Aisen, Paul; Mohs, Richard Journal: Alzheimer's & dementia Issue: Volume 4:Issue 1(2018) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing quality of life in Alzheimer's disease: Implications for clinical trials. Issue 1 (13th December 2016) Authors: Kahle‐Wrobleski, Kristin; Ye, Wenyu; Henley, David; Hake, Ann Marie; Siemers, Eric; Chen, Yun‐Fei; Liu‐Seifert, Hong Journal: Alzheimer's & dementia Issue: Volume 6:Issue 1(2017) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Issue 12 (4th November 2022) Authors: Simpson, Eric; Armstrong, April; Boguniewicz, Mark; Chiesa Fuxench, Zelma C.; Feely, Meghan; Pierce, Evangeline; Sun, Luna; Chen, Yun‐Fei; Angle, Robinette; Silverberg, Jonathan I. Journal: Dermatologic therapy Issue: Volume 35:Issue 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE‐AD7. (20th January 2023) Authors: Silverberg, Jonathan I.; Simpson, Eric L.; Thyssen, Jacob Pontoppidan; Werfel, Thomas; Cardillo, Tracy E.; Colvin, Stephanie; Pierce, Evangeline; Chen, Yun‐Fei; Chen, Sherry; Eichenfield, Lawrence Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 37:Number 5(2023) Page Start: 1036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O1–06–04: Efficacy of solanezumab in patients with mild or moderate Alzheimer's disease: Pooled analyses findings from two phase III studies. (1st July 2013) Authors: Carlson, Christopher; Sundell, Karen; Estergard, Wahiba; Raskin, Joel; Liu‐Seifert, Hong; Case, Michael; Sethuraman, Gopalan; Chen, Yun‐Fei; Henley, David; DeMattos, Ronald; Siemers, Eric Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 3 Page Start: P139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1‐366: USE OF QUANTILE REGRESSION TO CHARACTERIZE SOLANEZUMAB EFFECTS ACROSS PERCENTILES OF DISEASE PROGRESSION IN EXPEDITION ALZHEIMER'S DISEASE TRIALS. (1st July 2014) Authors: Chen, Yun‐Fei; Ma, Xiwen; Sundell, Karen; Alaka, Karla; Schuh, Kory; Raskin, Joel; Dean, Robert Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 11 Page Start: P448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1–342: Effects of solanezumab versus placebo administration on biomarkers in people with mild‐to‐moderate Alzheimer's disease: Results from two phase III clinical trials. (1st July 2013) Authors: Dean, Robert; Siemers, Eric; Carlson, Christopher; Estergard, Wahiba; Sundell, Karen; Henley, David; Hake, Ann; Eads, Jennifer; Sexton, Cora; Liu‐Seifert, Hong; Sethuraman, Gopalan; Chen, Yun‐Fei; Gonzales, Celedon; Lachno, D. Richard; Gelfanova, Valentina; Talbot, Jayne; Racke, Margaret; Mintun,... Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P4‐101: REGIONAL VARIATION IN ALZHEIMER'S DISEASE PROGRESSION IN A CLINICAL TRIAL SETTING. (1st July 2014) Authors: Henley, David B.; Dowsett, Sherie A.; Chen, Yun‐Fei; Liu‐Seifert, Hong; Grill, Joshua D.; Doody, Rachelle; Aisen, Paul; Raman, Rema; Miller, David S.; Hake, Ann Marie; Cummings, Jeffrey Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 22 Page Start: P821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quantile regression to characterize solanezumab effects in Alzheimer's disease trials. Issue 3 (16th August 2016) Authors: Chen, Yun‐Fei; Ma, Xiwen; Sundell, Karen; Alaka, Karla; Schuh, Kory; Raskin, Joel; Dean, Robert A. Journal: Alzheimer's & dementia Issue: Volume 2:Issue 3(2016) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials. (1st June 2022) Authors: Yosipovitch, Gil; Papp, Kim; Forman, Seth; Han, George; Waibel, Jill; Rueda, Maria J.; Sun, Luna; Chen, Yun‐Fei; Goldblum, Orin; Pierce, Evangeline; Silverberg, Jonathan I. Journal: British journal of dermatology Issue: Volume 186:Number 6(2022) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗